Jam today? Turning pharma's costs into assets
This article was originally published in Scrip
I recently came across details of a new economic theory being developed with environmental policy in mind that may have lessons for pharma. In a nutshell, the project – led by the FWF Austrian Science Fund, the central funding organization for basic research in Austria – is aimed at finding ways of rewarding people today for investing for the benefit of future generations.